Update on immunomodulating topical agents and NSAIDS.
Cuzzell
Janice Zeigler
JZ
Genentech, Inc., Savannah, GA, USA.
D000287:Administration, Topical; D003257:Consumer Product Safety; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced*
D016861:Cyclooxygenase Inhibitors; D007155:Immunologic Factors